Navigation Links
Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Date:12/15/2008

alidated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc. and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about APD597's development, therapeutic indication, efficacy and potential; the potential of the GDIR, including the potential to stimulate insulin release in response to increases in blood glucose; future activities under Arena's collaboration with Ortho-McNeil; the protocol, design, scope, enrollment and other aspects of the Phase 1 program for APD597; the inclusion of the evaluation of patients with type 2 diabetes in the planned clinical studies; and about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, the results of clinical trials or preclinical studies may not be predictive of future results, Arena's ability to receive regulatory approval for its drug candidates, Arena's ability to partner lorcaserin or other of its compounds or programs, the timing, success and cost of Arena's research, out-licensing endeavors and clinical trials, Arena's ability to obtain additional financing, Arena's ability to obtain and defend its patents an
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Spring Bank Pharmaceuticals, Inc., ... of viral infections, today announced that it has initiated ... its investigational, once daily, oral therapy for the treatment ... HCV-infected patients and is designed to assess both the ... is a first-in-class drug for the treatment of chronic ...
(Date:5/23/2013)... Israel , May 23, 2013 ... BrainTech Israel 2013 , Israel,s 1 ... on October 14 th -15 th in ... most innovative city in the world by the ... Nation." BrainTech Israel 2013 will showcase the latest ...
(Date:5/23/2013)... , May 23, 2013 ... announced today that the prize for ,Best Novel Idea, ... and Medical Emergency Teams International Conference, hosted this year ... was awarded to a clinical research team studying the ... California Hospital in Los Angeles . ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 2Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 3Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 4
... (CRL) has invested in a low-dose, state-of-the-art CT machine ... Minnesota.  This advanced diagnostic system will help physicians reach ... care with a radiation dose up to 40% lower ... "The addition of the GE Healthcare Brightspeed Elite CT ...
... ECRI Institute ®, an independent ... improving patient care, today announces the launch of its ... to ECRI Institute,s SELECTplus™ healthcare technology advisory service. The ... intelligence to help hospitals and health systems select and ...
Cached Medicine Technology:Consulting Radiologists, Ltd. Announces Addition of a Low Dose Advanced Computed Tomography (CT) System 2ECRI Institute Launches Market Analytics Tool to Help Hospitals Make More Informed Capital Purchasing Decisions 2ECRI Institute Launches Market Analytics Tool to Help Hospitals Make More Informed Capital Purchasing Decisions 3
(Date:5/23/2013)... On April 29th, 2013, UV Technologies issued ... H7N9 cases and deaths. The headline read, " UV Technologies, ... in Northern Hemisphere as Available Daylight Increases .” In fact, ... , Quoting Kevin McGuire, president of UV Technologies, "The ... in the spring and leaves changing in the fall. The ...
(Date:5/23/2013)... Cheap Concert Tickets announces that Paul ... at stadiums throughout North America. This well known ticket ... concert tickets to help McCartney fans see Sir Paul live ... states that she is also offering the customer appreciation code ... a baby boomer, she is also a huge McCartney fan ...
(Date:5/23/2013)... 23 (HealthDay News) -- The sensation of itching is ... back to a small molecule released in the spinal ... Researchers say this molecule, known as natriuretic polypeptide ... central nervous system. Ultimately, this signal is experienced as ... mice are similar, the researchers concluded that a similar ...
(Date:5/23/2013)... By Dennis Thompson HealthDay Reporter , , THURSDAY, ... soda can damage teeth as badly as methamphetamine or ... at it side-to-side with ,meth mouth, or ,coke mouth, ... of damage more or less the same," said Dr. ... Temple University School of Dentistry in Philadelphia. Methamphetamine, ...
(Date:5/23/2013)... virus isolated from a person who died from H7N9 ... infect and be transmitted between ferrets. Ferrets are often ... efficient transmission of influenza virus between ferrets can provide ... occur in people. The research was supported, in part, ... part of the National Institutes of Health. , The ...
Breaking Medicine News(10 mins):Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:Got an Itch? Mouse Study May Help Explain Why 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Ferrets, pigs susceptible to H7N9 avian influenza virus 2
... Researchers at the Mayo Clinic campus in Florida ... form of dementia that affects the brain areas associated with personality, ... of the American Journal of Human Genetics , ... progranulin and sortilin they say might open new avenues ...
... has filed an Investigational New Drug (IND) application with the ... Phase I safety trials to test NSI-189, its first small ... a proprietary new chemical entity discovered by Neuralstem that stimulates ... brain that is believed to be involved in depression. ...
... and Ergonomics Society has just released the newest volume ... annual series. Volume 6 reflects editor Douglas H. ... of expertise that exists in the Society and the ... we know about specific areas of human factors/ergonomicsstate of ...
... HealthDay Reporter , WEDNESDAY, Nov. 17 (HealthDay ... nerves has a striking effect on lowering blood pressure ... trying multiple drugs, Australian researchers report. Although this ... six months -- the authors believe the approach, which ...
... Reinberg HealthDay Reporter , WEDNESDAY, Nov. 17 ... in some adult vaccination rates, U.S. health officials reported ... should be. "We needed vaccinations as infants and ... Susan J. Rehm, medical director of the National Foundation ...
... mysterious culprit that threatens headaches, stuffy noses, skin rash ... people worldwide drink wine. The discovery could help winemakers ... and whites with less potential to trigger allergy symptoms, ... Journal of Proteome Research . Giuseppe ...
Cached Medicine News:Health News:New insight into the cause of common dementia found by researchers at Mayo Clinic 2Health News:New insight into the cause of common dementia found by researchers at Mayo Clinic 3Health News:Neuralstem files FDA application for first drug therapy 2Health News:Nerve Zap to Kidneys Might Ease Stubborn Hypertension 2Health News:Nerve Zap to Kidneys Might Ease Stubborn Hypertension 3Health News:CDC Report Finds Adult Vaccination Rates Still Lagging 2Health News:CDC Report Finds Adult Vaccination Rates Still Lagging 3
40-well gradient cycler...
... a high quality, compact thermal cycler. In addition ... Mastercycler personal offers first-rate operational flexibility. Its universal ... x 0.2 ml tubes, 16 x 0.5 ml ... grid format. Like the Mastercycler and the Mastercycler ...
... instrument and custom filter wheels with ... The standard filter set includes: FAM/SYBR ... Red (585nm-610nm), Cy5 (635nm-665nm) and Cy3 ... Mx3005P analysis software, Beacon Designer oligo ...
... The system includes: Mx3005P instrument and ... of five (5) filters. The standard ... (492nm-516nm), HEX/JOE/VIC (535nm-555nm), ROX/Texas Red (585nm-610nm), ... included: desktop computer, Mx3005P analysis software, ...
Medicine Products: